Prescription Drug Information: Divalproex Sodium (Page 11 of 11)

PRINCIPAL DISPLAY PANEL

DRUG: Divalproex Sodium

GENERIC: Divalproex Sodium

DOSAGE: TABLET, DELAYED RELEASE

ADMINSTRATION: ORAL

NDC: 70518-0463-0

NDC: 70518-0463-1

NDC: 70518-0463-2

COLOR: orange

SHAPE: OVAL

SCORE: No score

SIZE: 15 mm

IMPRINT: 797

PACKAGING: 30 in 1 BLISTER PACK

PACKAGING: 100 in 1 BOX

PACKAGING: 1 in 1 POUCH

ACTIVE INGREDIENT(S):

  • DIVALPROEX SODIUM 250mg in 1

INACTIVE INGREDIENT(S):

  • TALC
  • PROPYLENE GLYCOL
  • BUTYL ALCOHOL
  • FERROSOFERRIC OXIDE
  • SHELLAC
  • FERRIC OXIDE YELLOW
  • FD&C YELLOW NO. 6
  • SODIUM LAURYL SULFATE
  • SODIUM BICARBONATE
  • TRIETHYL CITRATE
  • METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
  • TRIACETIN
  • TITANIUM DIOXIDE
  • HYPROMELLOSE, UNSPECIFIED
  • POVIDONE, UNSPECIFIED
  • STARCH, CORN
  • AMMONIA
  • SILICON DIOXIDE
Remedy_Label
(click image for full-size original)
MM2
(click image for full-size original)
MM3
(click image for full-size original)
DIVALPROEX SODIUM divalproex sodium tablet, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70518-0463(NDC:62756-797)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DIVALPROEX SODIUM (VALPROIC ACID) VALPROIC ACID 250 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
STARCH, CORN
POVIDONE, UNSPECIFIED
HYPROMELLOSE, UNSPECIFIED
TITANIUM DIOXIDE
TRIACETIN
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
TRIETHYL CITRATE
SODIUM BICARBONATE
SODIUM LAURYL SULFATE
FD&C YELLOW NO. 6
FERRIC OXIDE YELLOW
SHELLAC
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
AMMONIA
TALC
Product Characteristics
Color orange Score no score
Shape OVAL Size 15mm
Flavor Imprint Code 797
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70518-0463-0 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK None
2 NDC:70518-0463-1 100 POUCH in 1 BOTTLE, UNIT-DOSE contains a POUCH (70518-0463-2)
2 NDC:70518-0463-2 1 TABLET, DELAYED RELEASE in 1 POUCH This package is contained within the BOTTLE, UNIT-DOSE (70518-0463-1)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078597 04/25/2017
Labeler — REMEDYREPACK INC. (829572556)

Revised: 01/2021 REMEDYREPACK INC.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.